Literature DB >> 22351816

Association of increased dermatologist density with lower melanoma mortality.

Savina Aneja1, Sanjay Aneja, Jeremy S Bordeaux.   

Abstract

OBJECTIVE: To determine whether there is an association between dermatologist density and melanoma mortality.
DESIGN: A regression model was developed to test the association between melanoma mortality and dermatologist density, controlling for county demographics, health care infrastructure, and socioeconomic factors. Data were collected from the Area Resource File, US Centers for Disease Control and Prevention, and National Cancer Institute's Surveillance, Epidemiology, and End Results program and National Program for Cancer Registries.
SETTING: US counties. PATIENTS: Melanoma mortality and incidence data were reported as age-adjusted mean rates per 100 000 people from January 2002, through December 2006. MAIN OUTCOME MEASURE: The primary outcome measure was melanoma mortality rate per 100 000 people at the county level.
RESULTS: Geographic variation exists in the distribution of dermatologists across the United States. Multivariate analysis demonstrated that the presence of 0.001 to 1 dermatologist per 100 000 people was associated with a 35.0% reduction in the melanoma mortality rate (95% CI, 13.4%-56.6%) when compared with counties with no dermatologist. The presence of 1.001 to 2 dermatologists per 100 000 people was associated with a 53.0% reduction in the melanoma mortality rate (95% CI, 30.6%-75.4%). Having more than 2 dermatologists per 100 000 people did not further lower melanoma mortality rates.
CONCLUSION: Within a given county, a greater dermatologist density is associated with lower melanoma mortality rates compared with counties that lacked a dermatologist.

Entities:  

Mesh:

Year:  2012        PMID: 22351816     DOI: 10.1001/archdermatol.2011.345

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  29 in total

1.  The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017.

Authors:  Melissa R Laughter; Mayra B C Maymone; Chante Karimkhani; Chandler Rundle; Sophia Hu; Sophia Wolfe; Katrina Abuabara; Parker Hollingsworth; Gil S Weintraub; Cory A Dunnick; Adnan Kisa; Giovanni Damiani; Aziz Sheikh; Jasvinder A Singh; Takeshi Fukumoto; Rupak Desai; Ayman Grada; Irina Filip; Amir Radfar; Mohsen Naghavi; Robert P Dellavalle
Journal:  JAMA Dermatol       Date:  2020-08-01       Impact factor: 10.282

2.  Association of Dermatologist Density With the Volume and Costs of Dermatology Procedures Among Medicare Beneficiaries.

Authors:  Sally Y Tan; Daphne Tsoucas; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2018-01-01       Impact factor: 10.282

3.  Analysis of Trends in Geographic Distribution of US Dermatology Workforce Density.

Authors:  Alex M Glazer; Darrell S Rigel
Journal:  JAMA Dermatol       Date:  2017-05-01       Impact factor: 10.282

4.  Are Primary Care Residents Trained to Perform Skin Cancer Examinations?

Authors:  Richard A Shellenberger; Karine Tawagi; Sweta Kakaraparthi; Jeremy Albright; Mohammed Nabhan; Alan C Geller
Journal:  J Gen Intern Med       Date:  2018-11       Impact factor: 5.128

5.  The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme.

Authors:  Sanjay Aneja; Dhruv Khullar; James B Yu
Journal:  J Neurooncol       Date:  2013-02-15       Impact factor: 4.130

6.  Comparison of Dermatologist Density Between Urban and Rural Counties in the United States.

Authors:  Hao Feng; Juliana Berk-Krauss; Paula W Feng; Jennifer A Stein
Journal:  JAMA Dermatol       Date:  2018-11-01       Impact factor: 10.282

7.  The Effect of Gynecologic Oncologist Availability on Ovarian Cancer Mortality.

Authors:  Sherri L Stewart; Darryl Cooney; Shawn Hirsch; Lauren Westervelt; Thomas B Richards; Sun Hee Rim; Cheryll C Thomas
Journal:  World J Obstet Gynecol       Date:  2014-05-10

8.  Comparison of Florida skin cancer screening rates with those in different US regions.

Authors:  Cristina A Fernandez; Laura A McClure; William G Leblanc; Tainya C Clarke; Robert S Kirsner; Lora E Fleming; Kristopher L Arheart; David J Lee
Journal:  South Med J       Date:  2012-10       Impact factor: 0.954

Review 9.  Discriminating Nevi from Melanomas: Clues and Pitfalls.

Authors:  Cristina Carrera; Ashfaq A Marghoob
Journal:  Dermatol Clin       Date:  2016-10       Impact factor: 3.478

Review 10.  Screening and prevention measures for melanoma: is there a survival advantage?

Authors:  Clara Curiel-Lewandrowski; Suephy C Chen; Susan M Swetter
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.